484
Views
8
CrossRef citations to date
0
Altmetric
Drug Evaluations

Sipuleucel-T and immunotherapy in the treatment of prostate cancer

, MD & , MD

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Bao-Chi Chang & Shyh-Jen Wang. (2015) The impact of patent eligibility on biotech patents: A flow chart for determining patent eligibility and an immune therapy case study. Human Vaccines & Immunotherapeutics 11:3, pages 789-794.
Read now
Federica Cavallo, Luigi Aurisicchio, Rita Mancini & Gennaro Ciliberto. (2014) Xenogene vaccination in the therapy of cancer. Expert Opinion on Biological Therapy 14:10, pages 1427-1442.
Read now

Articles from other publishers (6)

Ke-Tao Jin, Huan-Rong Lan, Xiao-Yi Chen, Shi-Bing Wang, Xiao-Jiang Ying, Yan Lin & Xiao-Zhou Mou. (2019) Recent advances in carbohydrate-based cancer vaccines. Biotechnology Letters 41:6-7, pages 641-650.
Crossref
Courtney Jarvis, Thomas Nelius, Dalia Martinez-Marin, Souad R. Sennoune & Stéphanie Filleur. (2018) Cabazitaxel regimens inhibit the growth of prostate cancer cells and enhances the anti-tumor properties of PEDF with various efficacy and toxicity. The Prostate 78:12, pages 905-914.
Crossref
Natalie Fekete, Ariane V. Béland, Katie Campbell, Sarah L. Clark & Corinne A. Hoesli. (2018) Bags versus flasks: a comparison of cell culture systems for the production of dendritic cell–based immunotherapies. Transfusion 58:7, pages 1800-1813.
Crossref
Guimiao Lin, Xiaomei Wang, Wanxian Yi, Chuanxia Zhang, Gaixia Xu, Xiaomei Zhu, Zhiming Cai, Yu Liu, Yuwen Diao, Marie Chia-Mi Lin & Guangyi Jin. (2015) A conjugate of octamer-binding transcription factor 4 and toll-like receptor 7 agonist prevents the growth and metastasis of testis embryonic carcinoma. Journal of Translational Medicine 13:1.
Crossref
Angus G Dalgleish. (2015) Rationale for combining immunotherapy with chemotherapy. Immunotherapy 7:3, pages 309-316.
Crossref
Robyn AA Oldham, Elliot M Berinstein & Jeffrey A Medin. (2015) Lentiviral vectors in cancer immunotherapy. Immunotherapy 7:3, pages 271-284.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.